Latest filing published 16 May 2018 for Neurogene Inc., €35k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Daniel J. Levitt: trading record in brief
Daniel J. Levitt is a declared insider at 2 companies; the most frequent names are Cytrx Corp and Neurogene Inc. The record holds 9 filings, for trades running from 22 February 2012 to 14 May 2018.
Market trades split into 1 purchase (€22k) and 1 sale (€41k). Sales outweigh purchases by €20k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 1 option exercise. In 2018 alone, the filings show no purchases and 1 sale.
On 16 May 2018 came the latest disclosure, an option exercise for €35k in Neurogene Inc. The latest purchase dates back some time: it was published 5,371 days ago, on 24 February 2012. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel J. Levitt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,906 shares@ US$10.5645.5% of flowCommon StockSEC:0001209191-18-030711:0
- 3,906 shares@ US$12.6754.5% of flowCommon StockSEC:0001209191-18-030711:1
- 100,000 shares0Common StockSEC:0001140361-14-003404:0
- 100,000 shares0Common StockSEC:0001140361-14-001804:0
- 100,000 shares0Common StockSEC:0001140361-14-000664:0
- 100,000 shares0Common StockSEC:0001140361-14-000434:0
- 100,000 shares0Common StockSEC:0001250853-13-000002:0
- 100,000 shares0Common StockSEC:0001250853-13-000001:0
- 100,000 shares@ US$0.2875Common StockSEC:0001250853-12-000024:0Canonical exit: 22 May 2012 (T+90)
9 of 9 declarations